F.D.A. Rejects Closely Watched Lung Cancer Drug From China

Start
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Previous Story

8 Takeaways From a Big Democratic Gathering in Denver: Democrats in Array

Next Story

Nvidia Fallout Looms Over Trump-Xi Meeting